BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its subsidiary, Designer Diagnostics, has received positive results from its in-vitro analysis of its Tuberculosis (TB) test kit.
